International Biotechnology Trust’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

International Biotechnology Trust’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-303,000	Closed	-$2.53M	–	63
2019 Q4	$2.53M	Sell	303,000 -47,000	-13%	-$432K	0.91%	28
2019 Q3	$3.17M	Buy	350,000 +200,000	+133%	+$2.24M	1.46%	18
2019 Q2	$1.62M	Buy	150,000 +102,000	+213%	+$1.08M	0.6%	40
2019 Q1	$457K	Hold	48,000	–	–	0.17%	60
2018 Q4	$432K	Sell	48,000 -65,000	-58%	-$807K	0.27%	42
2018 Q3	$1.46M	Hold	113,000	–	–	0.7%	37
2018 Q2	$1.6M	Buy	113,000 +60,000	+113%	+$997K	0.62%	39
2018 Q1	$1M	Sell	53,000 -132,000	-71%	-$2.82M	0.39%	51
2017 Q4	$3.03M	Sell	185,000 -88,000	-32%	-$1.31M	1.07%	29
2017 Q3	$4.09M	Buy	+273,000	New	+$3.02M	1.59%	21

Other funds holding SGMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

International Biotechnology Trust's SGMO Position: Q1 2020 in Review

International Biotechnology Trust sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2020, closing a stake of 303,000 shares — an estimated $2.53M sold.

International Biotechnology Trust first reported a position in SGMO in Q3 2017 and held it in 10 quarters. The position peaked at $4.09M in Q3 2017. 190 funds tracked by Wall St. Rank hold SGMO as of Q1 2020.

International Biotechnology Trust reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2020 after selling out during the quarter.
International Biotechnology Trust sold 303,000 SANGAMO THERAPEUTICS INC shares in Q1 2020, an estimated $2.53M.
International Biotechnology Trust first reported a position in SANGAMO THERAPEUTICS INC in Q3 2017 and held it in 10 quarters.
International Biotechnology Trust's SANGAMO THERAPEUTICS INC position peaked at $4.09M in Q3 2017.
190 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2020.

Based on International Biotechnology Trust's 13F filing for Q1 2020, filed 18 May 2020.